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Abstract
The ability to selectively activate function of particular proteins via pharmacological agents is a
longstanding goal in chemical biology. Recently, we reported an approach for designing a de novo
allosteric effector site directly into the catalytic domain of an enzyme. This approach is distinct
from traditional chemical rescue of enzymes in that it relies on disruption and restoration of
structure, rather than active site chemistry, as a means to achieve modulate function. However,
rationally identifying analogous de novo binding sites in other enzymes represents a key challenge
for extending this approach to introduce allosteric control into other enzymes. Here we show that
mutation sites leading to protein inactivation via tryptophan-to-glycine substitution and allowing
(partial) reactivation by the subsequent addition of indole are remarkably frequent. Through a
suite of methods including a cell-based reporter assay, computational structure prediction and
energetic analysis, fluorescence studies, enzymology, pulse proteolysis, x-ray crystallography and
hydrogen-deuterium mass spectrometry we find that these switchable proteins are most commonly
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modulated indirectly, through control of protein stability. Addition of indole in these cases rescues
activity not by reverting a discrete conformational change, as we had observed in the sole
previously reported example, but rather rescues activity by restoring protein stability. This
important finding will dramatically impact the design of future switches and sensors built by this
approach, since evaluating stability differences associated with cavity-forming mutations is a far
more tractable task than predicting allosteric conformational changes. By analogy to natural
signaling systems, the insights from this study further raise the exciting prospect of modulating
stability to design optimal recognition properties into future de novo switches and sensors built
through chemical rescue of structure.
Introduction
Important advances in cell biology have been enabled through the ability to selectively
activate proteins involved in key processes1–7. We recently described an approach for
introducing allosteric control into enzymes via a strategy termed “chemical rescue of
structure”8. This strategy entails introducing one or more cavity-forming mutations into a
protein core at “buttressing” locations, i.e. where specific sidechains are critical for
maintaining the structural integrity of the active site. Deletion of these “buttressing” residues
leads to distortion of the active site geometry, and accordingly loss of enzyme activity. The
subsequent addition of an exogenous compound that matches the deleted moiety is then
expected to restore the “buttress” by binding in the cavity, and thus restore protein structure
and activity.
Our previous studies8 focused on β-glycosidase from S. solfataricus as a model enzyme. We
introduced a tryptophan-to-glycine mutation (W33G) at a site close to (but distinct from) the
active site, and found the ratio kcat/Km for this mutant to be about 730-fold worse than that
of the wild-type enzyme. Upon solving the crystal structure of this mutant, we found that a
very local conformational change distinguished it from the wild-type structure: a single
nearby active site residue had shifted away from the active site to fill the cavity produced by
the mutation. The change in position of this active site residue led to a loss of contact with
the substrate, explaining the loss of function. We then found that exogenous indole could be
used to completely restore activity to the mutant, with both kcat and Km reaching the
corresponding values of the wild-type enzyme. The crystal structure of the mutant enzyme
in complex with indole revealed that indole occupied exactly the cavity created by the
mutation. This in turn perfectly restored the active site geometry, explaining the complete
rescue of enzyme activity.
In contrast to chemical rescue of structure, most approaches for building ligand-dependent
activity into enzymes have involved fusing a gene encoding some naturally-occurring
allosteric “binding domain” (for the desired ligand) into a gene encoding some naturally-
occurring “output domain” (for the desired activity)9. By using screens or selections to sift
through the large number of potential insertion points and linkers, these fusions of existing
protein domains have led to a variety of synthetic “switchable” proteins that are activated
through allostery by the binding of an effector ligand6,10–14. The chemical rescue of
structure approach is unique in that it introduces a ligand-binding site directly into the
“output domain,” rather than rely on allosteric coupling to a separate “binding domain.” This
alleviates the need for a naturally-occurring allosteric binding domain as a starting point, but
instead requires that ligand binding alters intradomain function.
In the β-glycosidase example described above, the structural consequences of the cavity-
forming mutation were indeed transduced to the active site, leading to loss and subsequent
rescue of function. However, identifying cavity-forming mutations that induce analogous
Xia et al. Page 2













conformational changes in other proteins represents a key challenge in building further de
novo switches and sensors by chemical rescue of structure. Here, we seek to explore the
general considerations that make this approach possible. In particular, we aim to address the
following questions: How frequently does a single W→G cavity-forming mutation induce
loss of function? How might one select sites that will lead to protein inactivation and
reactivation by indole? And most importantly, must we explicitly tackle the challenge of
modeling conformational changes resulting from cavity-forming mutations in order to
predict sites at which chemical rescue of structure may be applied?
Results
Reporter gene assay for loss of function and indole rescue
To explore the frequency at which a W→G mutation leads to loss of function, we developed
a reporter gene assay to monitor the loss and rescue of protein homodimerization in vivo. As
a starting point we used the cI repressor from λ phage, which is comprised of an N-terminal
DNA-binding domain and a C-terminal dimerization domain15. Upon homodimerization
induced by the C-terminal domain, the N-terminal domain recognizes a pR promoter to
repress downstream gene transcription16. To explore homodimerization in several different
proteins, we created chimeras by separately fusing each protein to the N-terminal domain of
cI. We expressed each chimera in E. coli that harbor a GFP gene under control of a pR
promoter, and monitored GFP fluorescence in these cell cultures. By coupling the target
construct dimerization (“function”) to transcriptional repression, this assay provides a
straightforward readout of the protein’s oligomeric state (Figure 1A).
We applied this assay to test a total of 14 W→G mutations in three separate functionally
unrelated E.coli genes that encode homodimeric proteins with available crystal structures:
yeaZ, orn, and tadA (Table S1). As controls we used the reporter gene plasmid without cI
repressor to monitor GFP fluorescence in the absence of repression (high RFUs), and we
used the wild-type cI repressor to estimate the expected maximal repression (low RFUs);
neither is strongly indole dependent. Chimeras produced by replacing the C-terminal domain
of cI with any of the three wild-type homodimeric proteins led to repression comparable to
that of the intact full-length wild-type cI repressor (Figure 1B, Table S2).
Upon introducing W→G mutations into these genes, we found that at least half disrupted
repression of the GFP gene (Figure 1B, Table S2). The extent of repression from these
mutants varied broadly: for example, yeaZ W134G and orn W9G had fluorescence
intensities 96-fold and 59-fold higher than their wild-type counterparts (Table S2). In
contrast, other mutants, such as yeaZ W169G and tadA W34G, maintained repressor activity
nearly equivalent to that of their wild-type counterparts.
Subsequent addition of 1 mM indole to the cell cultures appeared to rescue repression in a
number of cases: for example, yeaZ W123G, yeaZ W134G, yeaZ W159G, and orn W9G
(Figure 1B, Table S2). For the mutant showing the greatest indole-induced relative
difference in repression, yeaZ W123G, we further found that this enhanced repression
responded smoothly to the concentration of indole (Figure S1). Though these results suggest
that indole may restore dimerization in these mutants, the addition of indole did not result in
complete repression of fluorescence back to the wild-type levels, most likely because higher
concentrations of indole may be required for complete rescue8. Furthermore, despite the
unchanged the fluorescence levels of reporter plasmid alone and wild-type protein chimeras
upon addition of indole (Figure 1B, Table S2), we also cannot fully rule out the possibility
that indole may cause the observed decrease in fluorescence through some other unrelated
mechanism, such as unanticipated alterations in E. coli metabolism.
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While this experiment does not explicitly normalize for possible changes in expression
levels of our chimeric repressors, the observed differences in the behavior of W→G single-
point mutants within the same construct are unlikely to be attributable to altered expression
levels. To further investigate how structural changes upon incorporation of a W→G
mutation may lead to inactivation in this experiment, we turned to simulation studies of
these protein variants.
Structural analysis of mutations affecting dimerization
In order to develop a structure-based approach that would allow us to identify which
tryptophan sidechains would lead to loss of function when mutated to glycine, we first
labeled each tryptophan sidechain as “buttressing” (with respect to the dimer interface) or
“not buttressing.” Sites were labeled as “buttressing” if mutation to glycine led to at least 6-
fold loss of repression in the cI reporter assay; 7 of the 14 mutation sites met this criterion
(Table S2). We note that each of the proteins included in the cI assay has a different fold,
and that the mutation sites are dispersed across each protein (Figure 2A).
On the basis of our studies of indole rescue in β-glycosidase8, we expected that protein
inactivation would again result from an allosteric conformational change that coupled
disruption at the mutation site to distortion at the functional site (in this case, the dimer
interface). We further reasoned that such allosteric conformational changes—if not
explicitly evolved or designed—would be more likely to occur locally than over long
distances through the protein. As a first indirect test of this hypothesis, we therefore
computed the distance of each mutation site to the dimer interface (see Supporting
Information), with the expectation that the mutations closest to the dimer interface would
most frequently be those producing loss of repression in the cI assay.
To evaluate the accuracy of this approach for predicting the effect of these cavity-forming
mutations, we turned to receiver operating characteristic (ROC) analysis. Using the distance
to the interface as our predictor, we plotted the fraction of true positives identified in our set
(sites that are “buttressing” and are correctly classified as such) versus the fraction of false
positives (non-buttressing sites that are incorrectly classified as “buttressing”), for increasing
values of the discrimination distance threshold. Using this analysis, the curve for a perfect
predictor will rise vertically to the upper left corner of the plot; in contrast, a method that
makes predictions at random have a curve that approximately follows the diagonal (red
dashed line). While mutations to either of the two tryptophan sites closest to the dimer
interface indeed led to loss of repression (orn W9G and orn W143G), this approach failed to
readily identify the other five buttressing sites (Figure 2B); overall, this predictor performed
essentially as a random predictor.
To further explore the hypothesis that disruption at the mutation site could be coupled to
distortion of the dimer interface through some distinct conformational change, we used
structure prediction tools in the Rosetta macromolecular modeling suite17–19 to probe the
structural consequences of each mutation. We treated prediction of each mutant structure as
a comparative modeling task, using the crystal structure of the wild-type dimer as a template
for refinement (see Methods). For each of the resulting output structures, we evaluated the
interaction energy between the two subunits and compared it to the corresponding energy in
the wild-type structure: our hypothesis was that specific structural changes resulting from
mutations at buttressing residues might lead to disruption of interactions in the protein-
protein interface. However, this approach also performed essentially as a random predictor
(Figure 2C), suggesting that direct consideration of interface energetics—predicated on
building structural models from the wild-type template—was incapable of explaining why
certain W→G mutations led to loss of repression while others did not.
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We next surmised that perhaps these drastic cavity-forming mutations had destabilized the
protein to the point of inducing local or global unfolding20–23, in which case the crystal
structure of the wild-type dimer may not prove to be suitable template structure prediction.
Starting from the premise that the likelihood of a long-range allosteric conformational
change in response to an arbitrary mutation is rare, we postulated that a protein could
respond in three other ways to a W→G mutation: absorb the energetic cost of maintaining a
cavity in the hydrophobic core of the protein, undergo local collapse of nearby structure to
minimize the occupied volume in the core, or unfold. Given that the structural response to
mutations that decrease sidechain volume can vary substantially depending on context20, we
returned to the comparative models we had previously built. Using these models, in which
local reorganization may have been captured by our refinement protocol, we used Rosetta to
estimate the stability difference of each mutant (dimeric) protein relative to the
corresponding wild-type dimer (see Methods).
In stark contrast to the previous approaches, the estimated stability difference proved to be
an outstanding predictor of which W→G mutations would lead to loss of repression in the cI
assay (Figure 2D). We further note that the difference in average energy associated with
each mutant came not from a small number of outlying conformations, but rather from a
systematic shift in energy over the entire ensemble (Figure S2); while there is variation from
averaging over the set of conformations, the nature of these differences thus highlights the
robustness of this method for estimating stability differences.
In addition being a powerful binary classifier, the estimated stability difference also gave
quantitative correlation with the relative fluorescence measured in the cI reporter assay, with
Spearman rank correlation coefficient ρ=0.69, a statistically significant non-zero value (p <
0.008). The excellent predictive power of this approach supports the hypothesis that the loss
of dimerization in the cI repressor assay was caused by loss of protein stability rather than a
discrete conformational change. To test this novel mechanism for inactivation and rescue,
we next turned to direct biochemical characterization.
Mechanism of inactivation and rescue in +5 GFP
Due to the inherent challenges associated with the biochemical and structural
characterization of homodimers, we elected to explore whether the same stability-mediated
mechanism of inactivation and rescue occurred in a model system more naturally amenable
to these in vitro techniques. We selected +5 GFP for these studies, a variant of “superfolder”
GFP24. Like most GFP constructs, +5 GFP folds into a β-barrel harboring a single
tryptophan residue (Trp57) on the central helix, 10 Å from the chromophore24. Simulations
analogous to those described above gave an estimated stability difference of 4.5 Rosetta
energy units associated with this W57G mutation; this value nearly, but not quite, reaches
the threshold of 5.0 over which we regularly observed loss of function in the cI reporter
assay (Table S2).
We measured the fluorescence intensity of wild-type +5 GFP and its W57G mutant, and
found that deletion of this tryptophan sidechain reduced the fluorescence intensity by 50%
(Figure 3A). While addition of 1 mM indole led to a slight decrease in fluorescence intensity
for the wild-type protein, indole instead rescued fluorescence in the W57G mutant, back to
63% of the wild-type value (the difference in fluorescence intensity upon addition of indole
to +5 GFP W57G is statistically significant, p < 0.001 using Welch’s t-test). Rescue of
W57G fluorescence by indole increases in a dose-dependent manner (Figure S5).
It is well established that slight structural rearrangements close to the GFP chromophore can
lead to dramatic spectral differences25,26; the fluorescence properties can thus serve as a
sensitive readout of the local environment surrounding the chromophore. We therefore
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carried out excitation and emission wavelength scans for both GFP constructs (Figure 3B).
The shapes of the wild-type and W57G spectra are identical, notwithstanding a 46%
decrease in intensity upon mutation (consistent with Figure 3A). The addition of 1 mM
indole did not change either curve shape, save the same intensity differences observed
previously (Figure 3A). Collectively, the lack of peak shifts or additional peaks in these
spectra suggests that the partial inactivation and rescue we observed was not coupled to
reorganization of the packing around the chromophore.
Based on the unchanged excitation and emission maxima, we formulated the hypothesis that
in the absence of indole, +5 GFP W57G populates two states. The first, comprised of 46–
50% of the population, is characterized by a conformation very similar to that of wild-type
+5 GFP and accounts for the native-like excitation and emission spectra. The second state,
accounting for the remaining 50–54% of the population, may be partly unfolded or have
changes in conformational dynamics that disrupt the chromophore and result in loss of
fluorescence.
To test this hypothesis, we solved the crystal structure of +5 GFP W57G to 1.6 Å resolution
(Table S3). While it was somewhat surprising to obtain crystals from the heterogeneous
population we anticipated, we postulate that the (non-equilibrium) process of crystallization
allowed us to capture the native-like (fluorescent) state. Accordingly, our solved structure of
+5 GFP W57G closely resembles the structure of wild-type +5 GFP previously
determined24, with overall Cα RMSD of 0.84 Å (229 residues), Cα RMSD for residues
within 4 Å of the chromophore of 0.25 Å (21 residues), and no structural differences evident
in response to the mutation (Figure 3C). We also found that +5 GFP W57A exhibited similar
fluorescence properties as +5 GFP W57G including rescue by indole (Figures S3, S4), and
yielded crystals that diffracted to 1.1 Å resolution (Table S3). Like +5 GFP W57G, the
crystal structure of +5 GFP W57A showed no structural differences relative to the wild-type
structure, including the backbone at the site of the mutation (Figures S6, S7). Interestingly,
the +5 GFP W57A structure revealed a water molecule located exactly at the position
previously occupied by the indole nitrogen of Trp57, recapitulating the hydrogen bond to a
nearby aspartate observed in the wild-type structure (Figure S8). While both the W57G and
the W57A structures contain a large cavity previously filled by the tryptophan sidechain,
this cavity is neither completely occluded from solvent nor completely hydrophobic; this
makes it unsurprising that water occupies the space vacated by either mutation27.
With this evidence that fluorescence in +5 GFP W57G derives from a species having
essentially the wild-type structure, we next sought evidence for an alternate state comprising
the remainder of the population. To probe for such a state we carried out a pulse proteolysis
experiment, incubating either of wild-type +5 GFP or its W57G mutant with subtilisin. We
found that while the folded native structure of wild-type +5 GFP renders it largely protected
from proteolysis, the W57G mutant is extensively digested almost immediately (Figure 3D).
We further found that inclusion of a protease inhibitor (PMSF) in the reaction prevents loss
of +5 GFP W57G, while DMSO (used as a vehicle for PMSF) does not (Figure S9). The fact
that PMSF prevents the disappearance of W57G +5 GFP serves to confirm that indeed
proteolysis is responsible, and not some other process such as aggregation. The
susceptibility of +5 GFP W57G to proteolysis supports the hypothesis that in addition to a
state that strongly resembles wild-type +5 GFP, this mutant also populates a state in which
subtilisin cleavage sites are more exposed than in its native-like (fluorescent) conformation.
While we speculate that addition of indole would confer enhanced subtilisin resistance to
W57G +5 GFP, we found through separate control experiments (not shown) that indole
itself inhibits this protease directly; this made it impossible to test for indole rescue of
W57G +5 GFP subtilisin resistance.
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Collectively, these observations point to a model in which incorporation of the W57G
mutation into +5 GFP induces unfolding or enhanced fluctuations in a subset of the
population (loss of fluorescence intensity), followed by a shift in this population back to the
native-like state upon addition of indole (rescue of fluorescence intensity). This model is
qualitatively distinct from the mechanism of inactivation and rescue we observed in our
characterization of β-gly W33G8.
Mechanism of inactivation and rescue in β-glucuronidase
Motivated by this stability-mediated model for inactivation and rescue of +5 GFP W57G,
we returned to the E. coli β-glucuronidase (β-gluc) W492G mutant described previously8.
We had characterized this enzyme only in passing as part of our initial studies of indole
rescue, showing that indole could be used to partially restore activity to this mutant in a
dose-dependent manner. Though the structure of the wild-type enzyme has been solved via
X-ray crystallography28, we found that the W492G mutant was not amenable to
crystallization. We further applied the Rosetta refinement tools18,19 to build comparative
models of the W492G mutant, with the structure of the wild-type enzyme as a template;
none of these models, however, included a conformational change linking the mutation site
to the active site. In the absence of any structural insights we were, at the time, unable to
explain the basis for the loss of enzyme activity due to this mutation8, particularly given that
the mutation site lies 13 Å from the enzyme active site.
In light of the studies we reported above, we formulated the hypothesis that the indole-
dependent activity of β-gluc W492G may also be modulated by enhanced fluctuations or
local/global unfolding, which are then reverted upon addition of indole. This hypothesis
could explain our inability to form crystals of the W492G mutant, and also our inability to
build a compelling model of the structure of this protein. This hypothesis was further
supported by the stability difference of 6.5 Rosetta energy units estimated for this W57G
mutation, above the threshold of 5.0 that proved predictive in the cI reporter assay (Table
S2).
To directly test this hypothesis, we used hydrogen/deuterium (H/D) exchange experiments
to probe local fluctuation events in the protein. Upon incubation with deuterium-containing
solvent, amides that are not strongly hydrogen bonded are more rapidly isotopically labeled
than amides involved in intramolecular hydrogen bonds29–32. Consequently, hydrogen–
deuterium exchange allows us to localize conformational differences between β-gluc
variants or upon addition of indole. The large size of this enzyme precluded straightforward
residue-level localization of deuterium exchange information via NMR. For this reason, we
instead quenched the exchange reaction, used pepsin to digest the protein, and then
quantified the extent of exchange for each peptide fragment via mass spectrometry33 (see
Methods). A total of 147 peptides, of average length 13 residues, collectively covered 82%
of the whole protein sequence excluding proline residues (Figure S10); this included good
coverage near the active site and the mutation site (Figure 4A), and extensive overlap in
many regions. We separately incubated wild-type β-gluc and the W492G variant in
deuterium-containing buffer, both in the absence of indole and in the presence of 5 mM
indole. Aliquots at multiple time points were digested and analyzed by mass spectrometry to
determine the degree to which the protein environment conferred protection from exchange
at specific regions of the protein (see Supporting Information, Figure S11).
Relative to the wild-type enzyme, a number of segments from the W492G variant showed
enhanced deuterium uptake, corresponding to less protection by the protein environment.
Upon addition of indole, many of the same peptides exhibited decreased deuterium uptake,
suggesting that indole reverted the effect of this mutation (Figure S12). To allow direct
comparison between peptides of different sizes, we calculated for each peptide the
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“normalized deuterium difference”, NDD, defined as the difference in peptide mass increase
per exchangeable amide hydrogen, averaged over all time points (see Supporting
Information). To further localize the effect of mutation and indole rescue, we then returned
to the mapping of each peptide to the protein sequence. At every position in the protein
sequence, we assigned the normalized deuterium difference for the residue as the average
NDD value for all peptides covering its position in the sequence. While this does allow
calculation of an NDD value for all residues covered by at least one peptide, we note that
these NDD values are not truly residue-resolved, since each peptide represents information
integrated from adjacent residues as well as the residue of interest.
Relative to the wild-type enzyme, we observe enhanced deuterium uptake in the W492G
mutant that is localized to specific regions of the protein sequence (Figure 4B). Addition of
indole to the wild-type enzyme does not result in appreciable changes in deuterium uptake
(Figure 4C); in contrast, addition of indole to β-gluc W492G leads to protection against
deuterium uptake (Figure 4D). We further note that most of the regions in this mutant that
exhibit increased protection upon addition of indole are the same as those that showed
enhanced deuterium uptake as a result of the mutation. Upon comparing deuterium uptake
between wild-type β-gluc and W492G with 5 mM indole present in both, we find that indole
does not change the pattern but slightly reduces the magnitude of the differences (Figure
S13). Our observation that the enhanced deuterium uptake of the mutant is not fully
abrogated by addition of 5 mM indole is not surprising, given that we previously observed
only partial rescue of enzyme activity at this indole concentration8.
Mapping NDD values to the structure of the wild-type enzyme reveals a cohesive picture of
inactivation and rescue. First, introduction of the W492G mutation leads to less protection
from deuterium uptake in a nearby region that includes two helices and several intervening
loops, indicating that loss of function in response to this cavity-forming mutation occurs due
to enhanced fluctuations or local unfolding (Figure 4E). Addition of indole then restores
protection from deuterium uptake at the same regions (Figure 4F), suggesting rigidification
or refolding of these regions around the indole. These changes induced by addition of indole
(partially) shift the conformational ensemble back towards that of the wild-type enzyme,
thus providing a structural explanation for the previously-unexplained (partial) rescue of
enzyme activity8.
Discussion
In our earlier work8 we identified two examples of residues required for buttressing the
nearby active site: removal (via cavity-forming mutation) of a sidechain playing this key
role in maintaining the protein architecture results in collapse of the active site geometry,
and thus loss of function. Our structural studies of β-gly W33G revealed a distinct
conformational change induced by the cavity-forming mutation, which fortuitously
transduced this disruption to the active site. Predicting the long-range effects of structural
variations in general represents a very challenging problem34–40, making it exceedingly
unlikely that such predictions can be routinely used to introduce analogous mutations for
building allosteric control into other proteins.
The systematic evaluation of a larger test set in our cI repressor assay (Figure 1) and the
subsequent computational analysis (Figure 2), implied that protein structure and function
could instead be modulated indirectly, through control of protein stability. In both examples
for which we subsequently carried out detailed biochemical studies (Figure 3, 4), we found
strong evidence pointing to enhanced fluctuations or unfolding resulting from destabilization
as the mechanism underlying loss of function upon mutation. Accordingly, reactivation by
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indole may occur not only by reversion of a discrete conformational change (as in β-gly
W33G), but alternatively by rigidifying or refolding the protein to its active state.
It is also noteworthy that all of the proteins characterized here derive from mesophilic
organisms, whereas the β-glycosidase we studied previously derives from a
hyperthermophilic organism (Sulfolobus solfataricus). The extreme stability of β-gly may
have rendered it resistant to unfolding, allowing it to instead respond to the cavity-forming
mutation via the conformational change we described earlier8. In light of the results
presented here, we expect that modulation of function via chemical rescue of structure will
rely, for most proteins from mesophilic organisms, on stability-mediated mechanisms.
In order to build small-molecule dependence into a protein domain via chemical rescue of
structure, the cavity-forming mutation must induce the protein to undergo a transition to
some non-functional state (Figure 5); however, the precise details of this inactive state need
not be explicitly designed. Attempting to rationally identify cavity-forming mutations to
inactivate some protein of interest via a discrete conformational change would prove
exceedingly challenging; on the other hand, evaluating the stability difference associated
with cavity-forming mutations represents a far more tractable task. Accordingly, we expect
that the insights offered here will immediately enable rational design of a variety of new
protein switches that rely on activation by indole-induced protein stabilization, and will
prove highly complementary to techniques that use inducible “degron” fusions to modulate
degradation by the proteasome3,41.
Natural systems make use of small-molecules to encode a broad range of signals, whose
diversity is reflected in the wide variety of mechanisms that are used to transduce ligand
binding into downstream activity7. These mechanisms range from discrete conformational
changes42,43, to population shifts44–47, to induced folding48–51. Using chemical rescue of
structure, we have already observed a similar range of mechanisms for recognition and
activation in our set of designed protein switches.
The spectrum of available mechanisms for recognition enable natural systems to produce
switches with vastly different properties. There are specific design advantages associated
with using each distinct mechanism: these may include intrinsic differences in dynamic
range52, selectivity53,54, kinetics51,55, and the ability to modulate signals by altering cellular
accumulation through resistance to proteolysis50,56. The precise functional requirements
associated with responding to a particular stimulus can therefore be met, in part, by selecting
a recognition mechanism that will confer the desired kinetics, sensitivity, and dynamic
range7. The observation that our designed protein switches exhibit the same range of
mechanisms for activation as do natural switches raises the exciting prospect that – by
carefully selecting a protein host with appropriate structure and stability – we too can build
the desired activation mechanism into our protein switches. This, in turn, may enable us to
tune the specific properties of de novo switches built through chemical rescue of structure,




We transformed the reporter vector into E.coli cells DIAL strain JI57 to create the reporter
strain, then transformed the expression plasmids for cI–target fusion proteins into the
reporter strain. Cell cultures were split into equal aliquots, and indole was introduced into
the media for a final concentration of 1 mM using DMSO as a vehicle. 1% DMSO alone
was added to cell cultures not treated with indole. All experiments were carried out in
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triplicate. Fluorescence intensities of GFP were detected spectrophotometrically. Further
assay details are provided in Supporting Information.
Rosetta refinement protocol
We generated the starting structure of each W→G mutant by changing the amino acid
identity at the mutation site and removing sidechain atoms using a text editor. We then
performed 1000 independent simulations for each wild-type protein and W→G mutant in
our set, using the “relax” protocol17 in the Rosetta macromolecular modeling suite18. We
used the average energy of the 100 best-scoring output structures (10% of those generated)
to quantify the predicted interaction energy of the dimer interface or the relative stability of
the protein. Differences in the interaction energy of the dimer interface or in the protein
stability resulting from a mutation were estimated by subtracting the wild-type value from
that of the mutant. The simulation protocol is further described in Supporting Information.
Fluorescence measurements of +5 GFP
Fluorescence intensity was measured on a Synergy2 BioTek plate reader with a 485/20 nm
excitation filter and a 528/20 nm emission filter, using black 96-well plates. Ten replicates
were assayed for each sample. Excitation/emission scans were carried out using a Cary
Eclipse spectrophotometer (Varian) in a quartz cuvette.
All +5 GFP fluorescence studies (for wild-type, W57G, and W57A) were carried out using
9.5 µg/ml of protein with 5% DMSO and either no indole or 1 mM indole. Samples were
incubated for 1 hour prior to reading. Buffer conditions are described in Supporting
Information.
Crystal structures of +5 GFP mutants
Coordinates and structure factors for the crystal structures of +5 GFP W57G and W57A
have been deposited with the Research Collaboratory for Structural Bioinformatics Protein
Data Bank (PDB) with accession codes 4LQU and 4LQT, respectively. Crystallographic
methods and data are presented in Supporting Information.
Pulse proteolysis of +5 GFP
Samples of +5 GFP (wild-type or W57G) at 0.9 mg/ml were incubated with increasing
concentrations of subtilisin at 37°C. After 1 hour the proteolysis reaction was quenched by
adding an equal volume of SDS-PAGE loading buffer and heating at 95°C for 15 min.
Samples were analyzed by SDS-PAGE using Coomassie staining, and band intensities were
quantified using ImageJ58. Further details are provided in Supporting Information.
Hydrogen–deuterium exchange for β-glucuronidase
To initiate deuterium labeling, 0.5 µg/µL of wild-type or W492G β-gluc was diluted 20-fold
into D2O buffer with and without 5 mM indole. The reaction mixture was incubated at 25°C
for a time course ranging from 10 seconds to 12 hours, then was quenched using cold
hydrochloric acid to pH 2.6. Quenched protein samples were immediately digested with
pepsin. The peptides were separated by high-performance liquid chromatography and
analyzed by time-of-flight mass spectrometry. A complete description of these methods is
provided in Supporting Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Loss of function and indole rescue in a cell-based assay
(A) Schematic of the cI repressor assay. Various homodimeric proteins (pink) are fused to
the DNA-binding domain of cI repressor (yellow), enabling binding at the Pr promoter and
repression of the GFP gene. A W→G mutation that disrupts dimerization will lead to loss of
repression, and thus increased expression of GFP. If the subsequent addition of indole
rescues dimerization, repression will be restored and GFP expression will decrease. (B)
Effect of individual W→G mutations, and the subsequent addition of 1 mM indole,
determined by GFP expression in the cI repressor assay (relative fluorescence units, RFU).
More than half of the mutations disrupted repression of the GFP gene; repression could then
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be partially rescued by addition of indole in a number of cases. Notable examples exhibiting
loss of repression and subsequent rescue include yeaZ W123G, yeaZ W134G, yeaZ W159G,
and orn W9G. Figure S1 shows the effect of indole concentration on rescue of yeaZ W123G.
(Supporting Information).
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Figure 2. Structural analysis of mutations affecting dimerization
(A) Distribution of W→G mutation sites over the three homodimeric proteins used in the cI
assay. Mutation sites that led to loss of repression are shown in magenta, the other mutation
sites are shown in yellow. The dimer subunits are colored green and blue, respectively. (B)
A receiver operating characteristic (ROC) plot for predicting whether a given mutation will
lead to loss of repression in the cI assay, using the distance from the mutation site to the
dimer interface as the predictor. The area under the curve is 0.51, indicating that this method
performs about as well as making predictions purely at random (the red dashed line in each
ROC plot corresponds to a random predictor). (C) An analogous ROC plot generated by
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using the difference in interface energy of comparative models to predict whether a given
mutation will lead to loss of repression in the cI assay. The area under the curve is 0.41,
indicating that this method is not predictive of the data. (D) An analogous ROC plot
generated by using the estimated stability difference from the same set of comparative
models. The area under the curve is 0.94, indicating that this method performs much better
than a random predictor; the difference from a random predictor is statistically significant (p
< 0.004). The identification of stability difference as a successful predictor for loss of
function suggests that, at least in this experiment, changes in protein stability may underlie
inactivation/reactivation.
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Figure 3. Mechanism of inactivation and rescue in +5 GFP
(A) Fluorescence intensity of +5 GFP constructs, with excitation at 485 nm and emission at
528 nm. The indole concentration was 1 mM. Error bars indicate the standard error of the
mean from 10 replicate measurements. *** statistically significant difference at p < 0.001.
(B) Excitation and emission spectra of +5 GFP constructs. The indole concentration was 1
mM. (C) Crystal structure of W57G +5 GFP refined to 1.6 Å resolution (green and
magenta), superposed with wild-type superfolder GFP (gray and blue). (D) Coomassie-
stained SDS-PAGE gel showing products of pulse proteolysis reactions. Incubation with
subtilisin led to more extensive degradation of W57G +5 GFP (third lane) than of wild-type
+5 GFP (fourth lane). Figures S3–S9 include analogous plots showing fluorescence
properties of +5 GFP W57A, effect of indole concentration on +5 GFP W57G fluorescence,
crystallographic Fo-Fc omit maps, the complete (uncropped) gel from the pulse proteolysis
experiment, and a control experiment demonstrating that addition of the protease inhibitor
PMSF prevented W57G +5 GFP degradation, while DMSO vehicle alone did not.
(Supporting Information).
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Figure 4. Mechanism of inactivation and rescue in β-glucuronidase as revealed by hydrogen–
deuterium exchange analysis
(A) Peptic peptides provide thorough coverage of the β-gluc active site. Residues with an
exchangeable backbone amide hydrogen that were not covered by at least one peptide are
indicated in red; the remainder of the protein is shown in yellow. The locations of Trp492
(orange) and a substrate analog (blue) are shown in spheres. (B) Comparison of deuterium
uptake (“normalized deuterium difference”, NDD) between wild-type β-gluc and W492G;
positive values indicate enhanced deuterium uptake in the mutant. (C) Effect of adding 5
mM indole to wild-type β-gluc. (D) Effect of adding 5 mM indole to β-gluc W492G;
negative values indicate increased protection from deuterium uptake upon addition of
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indole. (E) Mapping the mutant versus wild-type NDD to the β-gluc protein structure reveals
a spatial localization of residues that undergo enhanced deuterium uptake in β-gluc W492G
relative to the wild-type. The color of each residue reflects the normalized deuterium
difference between the mutant and wild-type, using a gradient from purple (most enhanced
deuterium uptake in the mutant, relative to the wild-type) to green (most protected in the
mutant, relative to the wild-type). (F) Mapping the absence versus presence of indole NDD
to the β-gluc protein structure reveals the pattern of changes that occur upon addition of
indole. Each residue is colored using a gradient from purple (most enhanced deuterium
uptake upon addition of indole) to green (most protected upon addition of indole). Figure
S13 shows a comparison of deuterium uptake between wild-type β-gluc and W492G with 5
mM indole present in both; the mutant still exhibits greater deuterium uptake, suggesting
incomplete rescue at this indole concentration. (Supporting Information).
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Figure 5. United model of inactivation and rescue
A protein may respond to a cavity-forming W→G mutation by undergoing a discrete
conformational change, as seen in our previous study8, or through stability-mediated
mechanisms, as described here. Addition of indole re-activates the protein irrespective of the
underlying cause for loss of function.
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